This survival bias aligns with clinical results: higher TNF-alpha correlates with higher stage and worse prognosis (Hu et al., 2024[26]), and TNFR1 deficiency reduces tumor growth and metastasis (Yang et al., 2017[70]). This evidence concerns the gene TNFRSF1A and neoplasm.